MELODY KNIESS: Open Payments
NPI 1033508023 · NEW CASTLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,063 in 149 payments from 16 companies in 2025. Trend: 2023 $2,459 · 2024 $3,074 · 2025 $3,063
Food & beverage: $3,063
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $835 |
| UCB, Inc. | 22 | $469 |
| LEO Pharma Inc. | 9 | $282 |
| Janssen Biotech, Inc. | 16 | $275 |
| Novartis Pharmaceuticals Corporation | 17 | $267 |
| Galderma Laboratories, L.P. | 13 | $213 |
| Regeneron Healthcare Solutions, Inc. | 2 | $152 |
| PFIZER INC. | 6 | $105 |
| Incyte Corporation | 4 | $87 |
| GENZYME CORPORATION | 3 | $87 |
Products named: SKYRIZI, Bimzelx, TREMFYA, COSENTYX, RINVOQ, DUPIXENT, NEMLUVIO, ADBRY.
Industry payments across PA — which companies pay providers there.
